Mindfulness-Based Approaches to Insomnia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00768781|
Recruitment Status : Completed
First Posted : October 8, 2008
Last Update Posted : May 30, 2013
The overall goal of this project is to evaluate the evidence for the efficacy of two mindfulness-based interventions, mindfulness-based therapy for insomnia (MBT-I) and mindfulness-based stress reduction (MBSR), for reducing arousal and improving sleep among individuals with psychophysiological insomnia.
Specific Aim 1: To obtain evidence for the relative effects of MBT-I and MBSR compared to a delayed-treatment control condition followed by behavior therapy for insomnia (BT-I) on arousal levels. It is hypothesized that MBSR and MBT-I will be superior to the control condition at reducing arousal levels.
Specific Aim 2: To obtain evidence for the relative effects of MBT-I, MBSR, and the delayed-treatment control on sleep. It is hypothesized that MBT-I will be superior to the MBSR and control conditions at improving sleep parameters.
Specific Aim 3: To investigate the relationship between measures of arousal (self-report and objective measures) and sleep (self-report and objective measures) to enhance the understanding of the role of arousal in psychophysiological insomnia.
|Condition or disease||Intervention/treatment||Phase|
|Insomnia||Behavioral: Mindfulness-Based Stress Reduction Behavioral: Mindfulness-Based Therapy for Insomnia Behavioral: Wait-List + Behavioral Therapy for Insomnia||Phase 2|
The conceptual model for this study identifies two possible targets of treatment: arousal and sleep. In this model, BT for insomnia directly targets nighttime symptoms of insomnia (BT pathway), which improves sleep by increasing the homeostatic drive for sleep. Although BT is hypothesized to indirectly reduce arousal, no study has specifically investigated this effect. In contrast, MBSR is an intervention that is hypothesized to target arousal and, as preliminary findings suggest, also improves some symptoms of insomnia (MBSR pathway). It is therefore hypothesized that a combination of BT and mindfulness is superior to each treatment alone as it targets both nighttime symptoms and hyperarousal (Mindfulness + BT pathway). Our preliminary data suggests that this combination treatment has effects on both self-reported arousal and sleep. Conceptually, this novel approach would provide a set of self-regulating skills that could potentially target a broader range of daytime and nighttime symptoms that is characteristic of an insomnia disorder.
To test the conceptual model, this study employs a randomized clinical trial design with three conditions: 1) Mindfulness-Based Therapy for insomnia (MBT-I), 2) mindfulness-based stress reduction (MBSR), and 3) delayed-treatment condition followed by behavior therapy for insomnia (BT-I). Each of the three treatments will be delivered in a group format with 8 weekly sessions spanning an 8-week period.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||54 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Augmenting Behavior Therapy for Insomnia With Mindfulness Meditation|
|Study Start Date :||November 2008|
|Actual Primary Completion Date :||November 2012|
|Actual Study Completion Date :||April 2013|
|Active Comparator: Mindfulness-Based Stress Reduction||
Behavioral: Mindfulness-Based Stress Reduction
The rationale for treatment is that MBSR targets arousal, which is a prominent perpetuating factor of insomnia. Each session meets weekly for 120 minutes and consists of a therapist-led mindfulness meditation, followed by a discussion of the meditation and its application into the participant's everyday life. For homework, each participant is required to practice formal meditation at least 45 minutes a day, 6 days per week. Participants will be provided a tape, an mp3 file, or CD to aid in the participant's personal practice at home. Formal meditations that will be led and discussed include eating meditation, body scan, sitting meditation, Hatha Yoga, and walking meditation. In addition, informal mindfulness practices will be discussed.
|Active Comparator: Mindfulness-Based Therapy for Insomnia||
Behavioral: Mindfulness-Based Therapy for Insomnia
MBTI treatment includes the hypothesized active elements of both mindfulness meditation and behavior therapy for insomnia. The intervention includes 8 weekly sessions. Each session meets weekly for approximately 120 minutes. The general format of each session includes formal mindfulness meditation (quiet and movement meditations) and instructions for the behavioral intervention, with a focus on integrating the principles of mindfulness with these instructions. Each participant is required to practice formal meditation for at least 45 minutes a day, 6 days per week as homework. Participants are provided a tape, mp3 file, or CD to aid in the participant's personal practice at home.
|Behavioral Therapy for Insomnia (Delayed treatment condition)||
Behavioral: Wait-List + Behavioral Therapy for Insomnia
This delayed treatment condition consists of an 8-week monitoring period (sleep diaries, PSAS) and then BT. The BT treatment consists of 8 sessions of behavioral interventions for insomnia, with instructions targeting the nighttime symptoms of insomnia. The primary components of this treatment package are stimulus control, sleep restriction, and sleep hygiene education. In the BT condition, each weekly session lasts 120 minutes and consists of formal instructions for the behavioral interventions along with a time for discussion of the application of these instructions into each participant's unique circumstances.
- Pre-Sleep Arousal Scale (PSAS) total score [ Time Frame: Baseline, during txt, post-txt, 3 month follow-up, 6 month follow-up ]
- Sleep Diaries (Total Wake Time) [ Time Frame: Baseline, post-txt, 6 month follow-up ]
- Actigraphy measures of sleep/wake time [ Time Frame: Baseline, during txt, post-txt, 3 month follow-up, 6 month follow-up ]
- Polysomnographic measures of sleep parameters [ Time Frame: Baseline, post-txt, 6 month follow-up ]
- Insomnia Severity Index (ISI) total score [ Time Frame: Baseline, post-txt, 3 month follow-up, 6 month follow-up ]
- Five Factor Questionnaire (Mindfulness Skills) Total score [ Time Frame: Baseline, post-txt, 3 month follow-up, 6 month follow-up ]
- Dysfunctional Beliefs and Attitudes about Sleep (DBAS) score [ Time Frame: Baseline, post-txt, 3 month follow-up, 6 month follow-up ]
- Hyperarousal Scale (HAS) score [ Time Frame: Baseline, post-txt, 3 month follow-up, 6 month follow-up ]
- Heart Rate variability (HR) [ Time Frame: Baseline, post-treatment, 6-month follow-up ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00768781
|United States, Illinois|
|Sleep Disorders Center, Rush University Medical Center|
|Chicago, Illinois, United States, 60612|
|Principal Investigator:||Jason C Ong, PhD||Rush University Medical Center|